tlooto

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

L. Tan, Qi Wang, Duanyang Zhang, Jinya Ding, Qianchuan Huang, Yi-Quan Tang, Qiongshu Wang, Hongming Miao

2020.3.3SIGNAL TRANSDUCTION AND TARGETED THERAPY

Paper details

Journal
SIGNAL TRANSDUCTION AND TARGETED THERAPY
Published
2020.3.3
Citations
1,577
References
19
Access
Open Access
Fields
Medicine

tlooto Summary

A reliable Time from symptom onset-LYM% model (TLM) was established, which could be used to evaluate disease severity and predict the outcomes of hospitalized patients with COVID-19, and showed that LYM% in blood test were inversely associated with the progression and severity of CO VID-19.

Abstract

Background: Coronavirus disease-2019 (COVID-19) is a rapidly escalating epidemic caused by SARS-CoV-2. Identification of a simple and effective indicator to assess disease severity and outcome is urgently needed. Methods: This study retrospectively analyzed dynamic changes of lymphocyte percentage (LYM%) in 15 death cases, 15 severe cases as well as 40 moderate cases of COVID-19 patients. Next, prognostic role of lymphopenia in COVID-19 were verified in 92 hospitalized cases. Results: Our results from death and severe cases showed that LYM% in blood test were inversely associated with the progression and severity of COVID-19. LYM% in patients with moderate COVID-19 remained higher than 20% 10-12 days after symptom onset. In contrast, LYM% was lower than 20% in severe cases. However, LYM% in severe cases was higher than 5% 17-19 days after the onset of the disease, while it fell below 5% in death cases. Therefore, we established a reliable Time from symptom onset-LYM% model (TLM), which could be used to evaluate disease severity and predict the outcomes of hospitalized patients with COVID-19. Conclusion: Lymphopenia can be used to indicate clinical course, treatment effect and outcomes of COVID-19 patients.

Citation format

TAN, L., et al. Lymphopenia predicts disease severity of COVID-19: A descriptive and predictive study. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5(1): 33.